Skip to main content
Log in

Lymphadenectomy Should Be Performed Up to the Renal Vein in Patients with Intermediate-High Risk Endometrial Cancer

  • Research
  • Published:
Pathology & Oncology Research

Abstract

We aimed to evaluate para-aortic metastases relative to the level of inferior mesenteric artery (IMA) and to discuss the clinico-pathological features of these patients. A total of 204 patients who underwent systematic pelvic and para-aortic lymphadenectomy up to the level of renal veins for endometrial cancer between January 2007 and August 2013 were included in this study. Of these 204 patients, 44 (21.6 %) had lymph node involvement. From a total of 27 patients with paraaortic lymph node (PALN) metastasis, 11 had only supramesenteric and 4 had only inframesenteric nodal involvement, while 12 had both supramesenteric and inframesenteric metastases. Supramesenteric lymph node metastases were detected in 85.2 % of patients who have para-aortic metastases and in 11.3 % of all patients. Additionally, 5 patients had only supramesenteric lymphatic metastasis. The surgico-pathological characteristics of patients with isolated supramesenteric and inframesenteric metastasis were similar. However, the patients with lymphatic spread in both regions were found to have pelvic lymphatic metastasis and cervical invasion more commonly compared to patients with only supramesenteric or only inframesenteric metastasis. The site of metastatic lymph nodes wasn’t associated with the likelihood and site of recurrence. Lymphadenectomy should be performed up to the level of renal vein in case of the presence of indication for lymphadenectomy in patients with endometrial cancer. Additionally, it is not possible to predict the patients with supramesenteric lymph node involvement by tumor grade, histological type and myometrial invasion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Announcements (1989) FIGO (the International Federation of Obstetricians and Gynecologists) stages: 1988 revision. Gynecol Oncol 35:125–126

  2. Hoekstra AV, Kim RJ, Small W Jr et al (2009) FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Gynecol Oncol 114(2):273–278

    Article  PubMed  Google Scholar 

  3. McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R (2001) Analysis of FIGO Stage IIIC endometrial cancer patients. Gynecol Oncol 81(2):273–278

    Article  CAS  PubMed  Google Scholar 

  4. Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 60:2035–2041

    Article  CAS  PubMed  Google Scholar 

  5. Hirahatake K, Hareyama H, Sakuragi N et al (1997) A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 65:82–87

    Article  CAS  PubMed  Google Scholar 

  6. Mariani A, Keeney GL, Aletti G et al (2004) Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 92:833–838

    Article  PubMed  Google Scholar 

  7. Turan T, Hizli D, Sarici S et al (2011) Is it possible to predict para-aortic lymph node metastasis in endometrial cancer? Eur J Obstet Gynecol Reprod Biol 158(2):274–279

    Article  PubMed  Google Scholar 

  8. National Comprehensive Cancer Network (2006) Clinical practice guidelines in oncology, uterine cancers. Version 1. National Comprehensive Cancer Network, Washington, DC

    Google Scholar 

  9. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373(9658):125–136

    Article  Google Scholar 

  10. Chan JK, Cheung MK, Huh WK et al (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107(8):1823–1830

    Article  PubMed  Google Scholar 

  11. Fotopoulou C, Savvatis K, Kraetschell R, Schefold JC, Lichtenegger W, Sehouli J (2010) Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status. Eur J Obstet Gynecol Reprod Biol 149(2):199–203

    Article  PubMed  Google Scholar 

  12. Kumar S, Podratz KC, Bakkum-Gamez JN et al (2014) Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. Gynecol Oncol 132(1):38–43

    Article  PubMed Central  PubMed  Google Scholar 

  13. Nomura H, Aoki D, Suzuki N et al (2006) Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 16(2):799–804

    Article  CAS  PubMed  Google Scholar 

  14. Odagiri T, Watari H, Kato T, et al (2014) Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials. Ann Surg Oncol

  15. Chang SJ, Kim WY, Yoon JH, Yoo SC, Chang KH, Ryu HS (2008) Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Acta Obstet Gynecol Scand 87(12):1361–1369

    Article  PubMed  Google Scholar 

  16. Mariani A, Webb MJ, Galli L, Podratz KC (2000) Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76(3):348–356

    Article  CAS  PubMed  Google Scholar 

  17. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375(9721):1165–1172

    Article  PubMed  Google Scholar 

  18. Meeting Report (2009) The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas. Gynecol Oncol 115:325–328

    Article  Google Scholar 

  19. Turan T, Yilmaz SS, Hizli D et al (2011) A prospective evaluation of lymphatic dissemination in endometrial cancer: is it adequate to perform lymph node dissection up to the inferior mesenteric artery? Int J Gynecol Cancer 21(5):864–869

    Article  PubMed  Google Scholar 

  20. Creutzberg CL, van Putten WL, Koper PC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355(9213):1404–1411

    Article  CAS  PubMed  Google Scholar 

  21. National Comprehensive Cancer Network (2014) Clinical practice guidelines in oncology, uterine cancers. Version 1. National Comprehensive Cancer Network, Washington, DC

    Google Scholar 

  22. Yokoyama Y, Maruyama H, Sato S et al (1997) Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 64:411–417

    Article  CAS  PubMed  Google Scholar 

  23. Mariani A, Dowdy SC, Cliby WA et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11–18

    Article  PubMed Central  PubMed  Google Scholar 

  24. Burke TW, Levenback C, Tornos C et al (1996) Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 62:169–173

    Article  CAS  PubMed  Google Scholar 

  25. Maccauro M, Lucignani G, Aliberti G et al (2005) Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 32:569–574

    Article  PubMed  Google Scholar 

  26. Turan T, Hizli D, Sarici S et al (2012) What is the impact of cervical invasion on lymph node metastasis in patients with stage IIIC endometrial cancer? Arch Gynecol Obstet 285(4):1119–1124

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

Authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isin Ureyen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alay, I., Turan, T., Ureyen, I. et al. Lymphadenectomy Should Be Performed Up to the Renal Vein in Patients with Intermediate-High Risk Endometrial Cancer. Pathol. Oncol. Res. 21, 803–810 (2015). https://doi.org/10.1007/s12253-014-9893-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-014-9893-4

Keywords

Navigation